Enriched Eggs as a Source of N-3 Polyunsaturated Fatty Acids for Humans by Lewis, Nancy M. et al.
University of Nebraska - Lincoln 
DigitalCommons@University of Nebraska - Lincoln 
Nutrition and Health Sciences -- Faculty 
Publications Nutrition and Health Sciences, Department of 
2000 
Enriched Eggs as a Source of N-3 Polyunsaturated Fatty Acids for 
Humans 
Nancy M. Lewis 
University of Nebraska--Lincoln, nlewis2@unl.edu 
S. Seburg 
University of Nebraska--Lincoln 
N. L. Flanagan 
University of Nebraska--Lincoln 
Follow this and additional works at: https://digitalcommons.unl.edu/nutritionfacpub 
 Part of the Dietetics and Clinical Nutrition Commons 
Lewis, Nancy M.; Seburg, S.; and Flanagan, N. L., "Enriched Eggs as a Source of N-3 Polyunsaturated Fatty 
Acids for Humans" (2000). Nutrition and Health Sciences -- Faculty Publications. 3. 
https://digitalcommons.unl.edu/nutritionfacpub/3 
This Article is brought to you for free and open access by the Nutrition and Health Sciences, Department of at 
DigitalCommons@University of Nebraska - Lincoln. It has been accepted for inclusion in Nutrition and Health 
Sciences -- Faculty Publications by an authorized administrator of DigitalCommons@University of Nebraska - Lincoln. 
Enriched Eggs as a Source of N-3 Polyunsaturated Fatty Acids for Humans1
N. M. Lewis,*,2 S. Seburg,* and N. L. Flanagan*
*Department of Nutritional Sciences and Dietetics, University of Nebraska, Lincoln 68583-0806
ABSTRACT Dietary intake of omega-3 fatty acids (n-3
PUFA) decreases the risk of heart disease, inhibits the
growth of prostate and breast cancer, delays the loss of
immunological functions, and is required for normal fetal
brain and visual development. The US has not established
a recommended daily intake for n-3 PUFA. However,
Canada has established the Canadian Recommended Nu-
trient Intake (CRNI) at 0.5% of energy. Dietary sources
of n-3 PUFA include fish, chicken, eggs, canola oil, and
soybean oil. Food consumption studies in the US indicate
that the majority of Americans do not meet the CRNI for
n-3 PUFA. Mean n-3 PUFA consumption was 78% of
the CRNI for Midwestern women during pregnancy. In
Midwestern women at risk for breast cancer, the mean n-
3 PUFA consumption is approximately 50% of the CRNI.
Increased consumption of n-3 PUFA requires identifica-
tion of a food source that the public would eat in sufficient
amounts to meet recommended intake. N-3 PUFA-en-
riched eggs can be produced by modifying hens diets.
When 70 g/kg of cod liver oil, canola oil, or linseed oil
(Key words: omega eggs, omega-3 fatty acids, alpha-linolenic acid, docosohexaenoic acid, serum lipids)
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INTRODUCTION
Consumers are increasingly interested in functional
foods. One category of functional foods of great interest
are products that contain omega-3 fatty acids (n-3 PUFA).
Dietary intake of n-3 PUFA decreases risk of heart disease
(Temple, 1996), provides an inhibitory effect on the
growth of prostate and breast cancer (Pandalai et al., 1996;
Rose, 1997), delays the loss of immunological functions
(Fernandes, 1995), and is required for normal fetal brain
and visual development (Neuringer et al., 1998).
Food Sources and Dietary Intakes
Foods typically considered to be major contributors of
n-3 PUFA in the diet include fish and other types of
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are added to a commercial control diet, the n-3 PUFA are
increased from 1.2% of egg yolk fatty acids to 6.3, 4.6,
and 7.8%, respectively. Feeding flaxseed increases linole-
nic acid in the egg yolk about 30-fold, and docosahexae-
noic acid (DHA) increases nearly fourfold. When individ-
uals are fed four n-3 PUFA-enriched eggs a day for 4 wk,
plasma total cholesterol levels and low-density lipopro-
tein cholesterol (LDL-C) do not increase significantly.
Plasma triglycerides (TG) are decreased by addition of
n-3 PUFA-enriched eggs to the diet. N-3 PUFA may in-
fluence LDL particle size, causing a shift toward a less
atherogenic particle. Blood platelet aggregation is signifi-
cantly decreased in participants consuming n-3 PUFA-
enriched eggs. Overall results of studies to date demon-
strate positive effects and no negative effects from con-
sumption of n-3-enriched eggs. Three n-3 PUFA-enriched
eggs provide approximately the same amount of n-3
PUFA as one meal with fish. It is recommended that n-
3 PUFA-enriched eggs be used as one source of n-3 PUFA
to increase individual consumption to meet the current
Canadian recommendations.
seafood. Other common dietary sources of n-3 PUFA in-
clude chicken, eggs, canola oil, and soybean oil (Lewis et
al., 1995b). Less common food products that are high in
n-3 PUFA and can be obtained in health food stores are
wheat grass, fresh liquid lecithin, flaxseed, flaxseed oil,
and hemp seed oil. Other foods that provide smaller
quantities of n-3 PUFA include legumes, green vegeta-
bles, cauliflower, whole milk, and ground beef (Raper et
al., 1998).
Although fish is considered to be the primary source
of n-3 PUFA, it may not serve as a primary source for
people in certain parts of the country. For example, a
survey of Nebraskans indicates that fish is consumed only
once every 2 wk (Lewis et al., 1995a). In a survey of
pregnant women in the Midwest, the primary foods that
Abbreviation Key: CHD = coronary heart disease; CRNI = Canadian
Recommended Nutrient Intake; DHA = docosahexaenoic; EPA = eicosa-
pentaenoic acid; LDL-C = low-density lipoprotein cholesterol; LNA =
linolenic acid; MI = myocardial infarction; n-3 PUFA = omega-3 fatty
acids; TG = triglycerides.
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provided n-3 PUFA were fats, oils, and salad dressing,
dairy products, fish, and green vegetables (Lewis et al.,
1995b).
The US has not yet set a recommended dietary allow-
ance for n-3 PUFA. However, Canada has established the
Canadian Recommended Nutrient Intake (CRNI) at 0.5%
of energy, or 1.1 g of n-3 PUFA per day for an individual
consuming 2,000 kcal. The recommended ratio of n-6/n-
3 PUFA is 4 to 10:1 (Nutrition Recommendations, 1990).
Food consumption studies in the US indicate that many
Americans do not meet the CRNI for n-3 PUFA. Certain
population groups who have specific needs for n-3 PUFA
are at greater risk of n-3 PUFA deficiency. Lewis et al.
(1995b) surveyed 30 low-income pregnant Midwestern
women, ages 18 to 37, to determine their n-3 PUFA intake.
Mean n-3 PUFA consumption was 78% of the CRNI.
About half of the women consumed less than 75% of the
CRNI. Five of the 30 women met or exceeded the CRNI for
n-3 PUFA. A second survey was of Midwestern women at
risk for breast cancer (Bridger et al., 1998). The mean n-
3 PUFA consumption was 0.61 ± 0.24 g/d, approximately
50% of the Canadian RNI.
Increased consumption of n-3 PUFA requires identifi-
cation of food sources that the general public will con-
sume in sufficient amounts to meet recommended intake.
Eggs are a potential source of n-3 PUFA because they can
be easily enriched with n-3 PUFA by dietary modifica-
tions of the laying hens. The per capita consumption of
eggs in the US in 1996 was 238 (USDA, 1999), which is
approximately five eggs per person per week. If Ameri-
cans consumed five n-3 PUFA enriched eggs per week, the
amount of n-3 PUFA ingested would be approximately
equivalent to one five ounce serving of fish per week
(Scheideler and Lewis, 1997).
N-3 PUFA and Coronary Heart Disease
Epidemiology studies indicate that increased fish con-
sumption is related to a reduced incidence of myocardial
infarct. Daviglus et al. (1997) used data from the Chicago
Western Electric study to examine the relation between
base-line fish consumption and the 30-yr risk of death
from coronary heart disease (CHD). Men who consumed
35 g or more of fish per day had a 42% lower rate of
death from myocardial infarction (MI) when compared
with men who did not consume fish. Upon adjustment for
multiple confounders, a significant inverse relationship
prevailed between fish consumption and the risk of a
fatal MI. For the men who consumed 35 g or more of fish
daily as compared with the nonconsumers, the relative
risks of any death from MI and death from CHD was
0.56 and 0.62, respectively (P for trend = 0.02 and 0.04).
These trends were accounted for by the data on fatal MI,
specifically, by the trend toward a lower risk of nonsud-
den death from MI with higher fish consumption. The
relative risk of death from nonsudden MI for the men
who consumed 35 g or more of fish daily was 0.33 (P
for trend = 0.077). No significant relationship was found
between sudden death from MI and fish consumption.
Siscovick et al. (1995) conducted a case-control study
to assess whether the dietary intake of long-chain n-3
PUFA from seafood is associated with a reduced risk of
primary cardiac arrest. N-3 PUFA intake was assessed
both directly and indirectly through a biomarker. An in-
take of 5.5 g of n-3 PUFA per month was associated with
a 50% reduction in the risk of primary cardiac arrest
compared with no dietary intake of n-3 PUFA. A red
blood cell n-3 PUFA level of 5.0% of total fatty acids (the
mean of the third quartile), compared with a level of 3.3%
(the mean of the lowest quartile), was associated with a
70% reduction in the risk of primary cardiac arrest. The
results of this study suggest that dietary intake of n-3
PUFA from seafood is associated with a reduced risk of
primary cardiac arrest.
The relationship between fish consumption and re-
duced heart disease incidence may be explained by the
effects of the n-3 PUFA on heart rate. Presently CHD is
the major disease in which malignant ventricular arrhyth-
mias occur, and malignant ischemia is the most common
trigger of the arrhythmias. Kang and Leaf (1996) studied
the mechanism of the antiarrhythmic effects of PUFA in
vitro with cultured neonatal rat ventricular myocytes.
Reversible slowing of the beating rate with no change
in the amplitude of contraction invariably occurs with
addition of eicosapentaenoic acid (EPA) and docosahex-
aenoic acid (DHA). Tachyarrhythmias occurred in the
myocytes with addition of agents known to cause ar-
rhythmias in patients. These tachyarrhythmias were pre-
vented or abolished by a low concentration of n-3 PUFA
added to the perfusing medium.
N-3 PUFA-Enriched Eggs and
Their Effects on Serum Lipids
N-3 PUFA-enriched eggs can be produced by modi-
fying hen diets. Scheideler and Froning (1996) conducted
a study to determine how modifying hen diets would
change the fatty acid composition of the egg yolks. The
hens were assigned to control, 15% fish oil, or 5, 10, or 15%
flaxseed dietary rations. The n-3 PUFA were significantly
higher in eggs produced from hens fed fish oil or flaxseed
as compared with the control. The amount of n-3 PUFA
in the egg yolks of the control and treatment groups were
1.2% of fatty acids, or 2.0 to 7%, respectively. Scheideler
et al. (1997) studied consumer acceptance of n-3 fatty
acid-enriched eggs and found little taste differentiation
among scrambled control versus n-3-enriched eggs. Fer-
rier et al. (1995) utilized flax seed to increase the n-3 PUFA
in eggs. They fed a control diet or linolenic acid (LNA)
diet that contained 10 or 20% flaxseed. In the modified
eggs, the n-3 PUFA, LNA, increased from 28 mg per egg
in the control to 261 and 527 mg per egg in the modified
eggs, respectively. The DHA content increased from 51
mg per egg to 81 and 87 mg per egg.
Scheideler and Froning (1996) have also produced n-3
PUFA-enriched eggs from hens fed flaxseed. The modi-
fied egg contains 350 mg of n-3 PUFA compared with
the standard egg that contains 60 mg of n-3 PUFA. The
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LNA content is 250 mg and the DHA content is 100 mg
in the modified egg compared with the standard egg that
contains 40 mg and 20 mg, respectively. The ratio of n-
6/n-3 PUFA is 13.0 in a standard egg compared with a
ratio of 2.6 in the modified egg. Cholesterol content in
the modified egg has also been reduced to 180 mg per
egg, compared with the standard egg value of 210 mg
per egg. Nutrient content in other aspects such as energy,
protein, and carbohydrate are similar to a standard egg
(Scheideler and Lewis, 1997).
One of the barriers to increasing n-3 PUFA consump-
tion with n-3 PUFA-enriched eggs is consumer perception
that increasing egg consumption and, therefore, increas-
ing cholesterol consumption is unhealthy. The American
Heart Association (1999) recommends consuming no
more than 3 to 4 egg yolks per week. Therefore, initial
studies with n-3 PUFA-enriched eggs have been con-
ducted to assess the effects of these eggs on serum lipids
profiles as well as other health factors.
Ferrier et al. (1995) compared the effects of four n-3
PUFA eggs per day or four standard eggs per day on
serum lipids in 28 normolipidemic subjects. After 2 wk,
no significant changes were observed in total cholesterol,
high-density lipoprotein cholesterol, or plasma triglycer-
ide (TG) concentrations. However, consumption of modi-
fied eggs resulted in a significant increase in DHA and
total n-3 PUFA in the blood platelet phospholipids.
Lewis et al. (2000) fed 12 regular or 12 n-3 PUFA-
enriched eggs per week to hypercholesterolemic partici-
pants who were consuming a low-fat diet. After 6 wk,
the majority of the participants showed no response in
total or low-density lipoprotein cholesterol (LDL-C) to
either of the egg treatments. However, 2 of the 25 partici-
pants responded to the increase in dietary cholesterol
with a significant increase in both serum total and LDL-
C. These two participants were identified as responders,
and the data were analyzed both with and without the
responders. In the nonresponders, no significant effects
of the diets were found on any of the serum lipids with
the n-3 PUFA-enriched eggs or the standard eggs added
compared with the no-egg diet. The largest effect in the
nonresponders was a 14% reduction in TG when the n-
3 PUFA-enriched egg was consumed. When the data from
the responders were added to the analysis, there was a
significant increase in LDL-C with the egg treatments (P
< 0.01) and a significant decrease in serum TG during the
dietary period that included the n-3 PUFA-enriched eggs
(P < 0.05). For the majority of the population, consumption
of two eggs per day does not appear to have negative
effects on blood lipid patterns. However there is a certain
subset of the population (i.e., responders) for whom in-
creasing n-3 PUFA via n-3 PUFA-enriched eggs would
not be appropriate.
Another mechanism that may explain the relationship
between n-3 fatty acid and CHD is the effect of n-3 PUFA
on platelet aggregability. Van Elswyk et al. (1998) fed
volunteers four n-3 PUFA enriched eggs per week or four
regular eggs per week for 6 wk. Blood platelet aggregabil-
ity was measured at baseline and following 6 wk of di-
etary treatment. After the treatment period, there was a
significant decrease in the platelet aggregation when the
volunteers consumed the n-3 PUFA-enriched eggs.
CONCLUSION
In conclusion, consumption of n-3 PUFA in the Mid-
west is approximately half of that recommended by the
CRNI. Because this population is already eating more
eggs than fish, n-3 PUFA-enriched eggs are an alternative
source of n-3 PUFA. The n-3 PUFA-enriched eggs do not
appear to have negative effects on serum lipids in the
majority of the population. Future research needs to focus
on the relationship of consumption of n-3 PUFA-enriched
eggs and risk of heart disease. It is recommended that n-
3 PUFA-enriched eggs be used as one source of n-3 PUFA
to increase individual consumption to levels that will
meet the current CRNI.
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